These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cyclooxygenase-2 deficiency exacerbates bleomycin-induced lung dysfunction but not fibrosis. Card JW; Voltz JW; Carey MA; Bradbury JA; Degraff LM; Lih FB; Bonner JC; Morgan DL; Flake GP; Zeldin DC Am J Respir Cell Mol Biol; 2007 Sep; 37(3):300-8. PubMed ID: 17496151 [TBL] [Abstract][Full Text] [Related]
3. Prevention of bleomycin-induced lung fibrosis in mice by a novel approach of parallel inhibition of cyclooxygenase and nitric-oxide donation using NCX 466, a prototype cyclooxygenase inhibitor and nitric-oxide donor. Pini A; Viappiani S; Bolla M; Masini E; Bani D J Pharmacol Exp Ther; 2012 May; 341(2):493-9. PubMed ID: 22344408 [TBL] [Abstract][Full Text] [Related]
5. Effects of New NSAID-CAI Hybrid Compounds in Inflammation and Lung Fibrosis. Lucarini L; Durante M; Sgambellone S; Lanzi C; Bigagli E; Akgul O; Masini E; Supuran CT; Carta F Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32927723 [TBL] [Abstract][Full Text] [Related]
6. Bleomycin-induced E prostanoid receptor changes alter fibroblast responses to prostaglandin E2. Moore BB; Ballinger MN; White ES; Green ME; Herrygers AB; Wilke CA; Toews GB; Peters-Golden M J Immunol; 2005 May; 174(9):5644-9. PubMed ID: 15843564 [TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system. Kirkby NS; Lundberg MH; Harrington LS; Leadbeater PD; Milne GL; Potter CM; Al-Yamani M; Adeyemi O; Warner TD; Mitchell JA Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17597-602. PubMed ID: 23045674 [TBL] [Abstract][Full Text] [Related]
10. Hepatocyte Growth Factor Is Required for Mesenchymal Stromal Cell Protection Against Bleomycin-Induced Pulmonary Fibrosis. Cahill EF; Kennelly H; Carty F; Mahon BP; English K Stem Cells Transl Med; 2016 Oct; 5(10):1307-1318. PubMed ID: 27388243 [TBL] [Abstract][Full Text] [Related]
11. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice. Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720 [TBL] [Abstract][Full Text] [Related]
12. Vasoconstrictor role of cyclooxygenase-1-mediated prostacyclin synthesis in non-insulin-dependent diabetic mice induced by high-fat diet and streptozotocin. Zhu N; Liu B; Luo W; Zhang Y; Li H; Li S; Zhou Y Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H319-27. PubMed ID: 24878773 [TBL] [Abstract][Full Text] [Related]
14. Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis. Black KE; Berdyshev E; Bain G; Castelino FV; Shea BS; Probst CK; Fontaine BA; Bronova I; Goulet L; Lagares D; Ahluwalia N; Knipe RS; Natarajan V; Tager AM FASEB J; 2016 Jun; 30(6):2435-50. PubMed ID: 27006447 [TBL] [Abstract][Full Text] [Related]
15. Contribution of cyclooxygenase-1-dependent prostacyclin synthesis to bradykinin-induced dermal extravasation. Krybus M; Sieradzki M; Fahimi E; Metry S; Nüsing R; Geisslinger G; Steiner I; Daldrup T; Lehr M; Kojda G Biomed Pharmacother; 2022 Apr; 148():112786. PubMed ID: 35259564 [TBL] [Abstract][Full Text] [Related]
16. COX-2/sEH dual inhibitor PTUPB alleviates bleomycin-induced pulmonary fibrosis in mice via inhibiting senescence. Zhang CY; Duan JX; Yang HH; Sun CC; Zhong WJ; Tao JH; Guan XX; Jiang HL; Hammock BD; Hwang SH; Zhou Y; Guan CX FEBS J; 2020 Apr; 287(8):1666-1680. PubMed ID: 31646730 [TBL] [Abstract][Full Text] [Related]
17. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis. Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424 [TBL] [Abstract][Full Text] [Related]
18. Roles of high-mobility group box 1 and thrombin in murine pulmonary fibrosis and the therapeutic potential of thrombomodulin. Kida T; Seno T; Nagahara H; Inoue T; Nakabayashi A; Kukida Y; Fujioka K; Fujii W; Wada M; Kohno M; Kawahito Y Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L473-L483. PubMed ID: 29212801 [TBL] [Abstract][Full Text] [Related]
19. Role of cyclooxygenase-1 and -2 in endothelium-dependent contraction of atherosclerotic mouse abdominal aortas. Li S; Liu B; Luo W; Zhang Y; Li H; Huang D; Zhou Y Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):67-74. PubMed ID: 26444418 [TBL] [Abstract][Full Text] [Related]
20. E- and P-selectins synergistically inhibit bleomycin-induced pulmonary fibrosis. Horikawa M; Fujimoto M; Hasegawa M; Matsushita T; Hamaguchi Y; Kawasuji A; Matsushita Y; Fujita T; Ogawa F; Takehara K; Steeber DA; Sato S Am J Pathol; 2006 Sep; 169(3):740-9. PubMed ID: 16936251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]